Oxandrolone is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Upsher-smith Laboratories, Llc. The primary component is Oxandrolone.
Product ID | 0245-0271_24672ff6-88f0-4cb5-95c0-12d9907534f5 |
NDC | 0245-0271 |
Product Type | Human Prescription Drug |
Proprietary Name | Oxandrolone |
Generic Name | Oxandrolone |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2006-12-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA076761 |
Labeler Name | Upsher-Smith Laboratories, LLC |
Substance Name | OXANDROLONE |
Active Ingredient Strength | 3 mg/1 |
DEA Schedule | CIII |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2006-12-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA076761 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-12-01 |
Marketing Category | ANDA |
Application Number | ANDA076761 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-12-01 |
Marketing Category | ANDA |
Application Number | ANDA076761 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2006-12-01 |
Marketing Category | ANDA |
Application Number | ANDA076761 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-12-01 |
Ingredient | Strength |
---|---|
OXANDROLONE | 2.5 mg/1 |
SPL SET ID: | b4ba1f43-5628-4e79-a4aa-f5c466cb517a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0245-0271 | Oxandrolone | Oxandrolone |
0245-0272 | oxandrolone | oxandrolone |
49884-301 | Oxandrolone | oxandrolone |
49884-302 | Oxandrolone | oxandrolone |
63629-7603 | Oxandrolone | oxandrolone |
68084-424 | Oxandrolone | oxandrolone |
68084-425 | Oxandrolone | oxandrolone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
OXANDROLONE 85354270 4126968 Live/Registered |
PBB TRADEMARK HOLDINGS, LLC 2011-06-23 |